Programme
Wednesday, 6 November
|
10:00 |
Registration opens for individuals participants and for groups |
Thursday, 7 November
|
9:00 19:30 |
Exhibition |
| 9:00 |
Breast cancer patient advocacy session Introductions and greatest challenges in meeting the needs of patients with advanced breast cancer |
| 9:00 |
Satellite symposium 1 |
|
10:30 |
Coffee break |
| 11:00 |
Breast cancer patient advocacy session Challenges and guidelines in advanced breast cancer |
| 11:00 |
Celgene International Satellite symposium |
|
12:30 |
Lunch |
|
13:30 |
Opening session (Chairs: F. Cardoso, PT - L. Norton, US) |
| 13:30 |
Opening and introduction (Chair: F. Cardoso, PT) |
| |
- Welcome to Lisbon (N. Cabral, President of the Port of Lisbon, PT)
- Keynote lecture
A personal journal through advanced breast cancer (D. Fenech, MT) |
|
14:15 |
Major advances since ABC1 (Chair: E.P. Winer, US) |
| |
- Advances in HER-positive advanced breast cancer (I.E. Krop, US
- Advances in TN advanced breast cancer (G.W. Sledge, US)
- Advances in endocrine therapy and endocrine resistance (M.J. Piccart, BE)
- Advances in cytotoxic and other targeted therapy (J. Gligorov, FR)
- Advances in imaging (A.R. Padhani, UK)
- Discussion
|
|
16:15 |
Coffee break |
|
16:45 |
Best abstract presentations (Chair: A. Costa, IT/CH) |
| |
- Basic and translational research
- Clinical issues
- Nursing and patient advocacy
|
|
17:30 |
ABC Award and Lecture: Deconstructing metastasis (Awardee: J. Massagué, US) |
| 18:00 |
Breast cancer patient advocacy session How can the ABC guidelines address global challenges? |
| 18:00 |
Satellite symposium 3 |
| 19:30 |
Welcome cocktail |
Friday, 8 November
|
9:00 19:30 |
Exhibition |
|
9:00 |
Inoperable locally advanced breast cancer (part I) (Chairs: F. Cardoso, PT - E.P. Winer, US) |
|
|
- The biology of locally advanced breast cancer: Inflammatory and non-inflammatory (F. Pernault-Llorca, FR)
- Epidemiology and geographic differences (E. Senkus-Konefka, PL)
- Systemic therapy: Optimal strategies and therapies (N. Harbeck, DE)
- Discussion
|
|
10:15 |
Coffee break |
|
10:45 |
Inoperable locally advanced breast cancer (part II) (Chairs: F. Cardoso, PT - E.P. Winer, US) |
| |
- Radiotherapy: Best timing and techniques (C. Vrieling, CH)
- Surgery: Challenges and opportunities (M.J. Cardoso, PT)
- Discussion
|
|
11:40 |
Specific populations (Chair: K. Gelmon, CA) |
| |
- Metastatic male breast cancer (S.H. Giordano, US)
- BRCA-related advanced breast cancer (P.A. Francis, AU)
- Discussion
|
| 12:30 |
Survivorship in advanced breast cancer Panel discussion (Chair: K. Redmond, CH; Panelists: O. Pagani, CH; Ann H. Partridge, US; S. Kyriakides, CY; M. Mayer, US; L. Fallowfield, UK and N. West, UK) |
| 13:00 |
Lunch and poster session |
| 14:00 |
Specific metastatic sites (Chair: H. Rugo, US - F. André, FR) |
| |
- Multidisciplinary approach to liver metastases (C.H. Barrios, BR)
- Update on brain metastases management (N.U. Lin, US)
- Optimal management of pleural effusions (B. Kaufman, IL)
- Chest wall recurrences and cutaneous metastases (K.L. Blackwell, US)
- Can specific sites of metastases be predicted and prevented? (L. van 't Veer, US)
- Discussion
|
| 15:40 |
Special session (Chair: L. Norton, US) |
| |
- The role of mathematical and computer modeling for metastases research (S.D. Merajver, US)
- Discussion
|
| 16:00 |
Coffee break |
| 16:30 |
Supportive and palliative care issues (Chair: M.S. Aapro, CH and G.W. Sledge, US) |
| |
- Optimal pain control (L. Biganzoli, IT)
- Optimal management of nausea and vomiting (J. Bergh, SE)
- Psycological support: When and how? (L. Fallowfield, UK)
- Patient perspective on symptom control (M. Mayer, US)
- Disparities in access to supportive/palliative specialised care (R.A. Badwe, IN)
- Discussion
|
| 18:00 |
Breast cancer patient advocacy - Meet the expert session Where will we be in the coming years? (K. Redmond, CH) |
| 18:00 |
Novartis Oncology Satellite symposium Advanced breast cancer cases - Packing for the journey |
Saturday, 9 November
|
9:00 13:00 |
Exhibition |
|
9:00 |
Consensus session (Part I) |
|
10:30 |
Coffee break |
|
11:00 |
Consensus session (Part II) |
| 12:30 |
Report from ABC patient advocacy committee |
|
13:00 |
Close |
A/V RECORDING DURING THE CONFERENCE IS PROHIBITED
Consensus session
The Panel will update the ABC consensus recommendations for the management of advanced breast cancer continuing the work developed during ABC1. The ABC2 consensus manuscript will be published after the meeting.
|